Atlas Trials

ECOG PS 0 to 2 Points

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ECOG PS 0 to 2 Points

RecordFirmDate
the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy (NCT05497076)Fujian Cancer Hospital2022-09-01

Track ECOG PS 0 to 2 Points automatically

Every clearance here is in the API, with alerts when new ones post.